SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024611
Filing Date
2022-11-14
Accepted
2022-11-14 06:06:49
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20220930.htm   iXBRL 10-Q 3361465
2 EX-31.1 elym-ex31_1.htm EX-31.1 20593
3 EX-31.2 elym-ex31_2.htm EX-31.2 20651
4 EX-32.1 elym-ex32_1.htm EX-32.1 13283
5 EX-32.2 elym-ex32_2.htm EX-32.2 13362
6 GRAPHIC img156758966_0.jpg GRAPHIC 287593
  Complete submission text file 0000950170-22-024611.txt   10859513

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20220930.xsd EX-101.SCH 53059
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20220930_lab.xml EX-101.LAB 419030
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20220930_cal.xml EX-101.CAL 37374
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20220930_def.xml EX-101.DEF 155799
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20220930_pre.xml EX-101.PRE 318001
59 EXTRACTED XBRL INSTANCE DOCUMENT elym-20220930_htm.xml XML 2071342
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 221379579
SIC: 2834 Pharmaceutical Preparations